Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 71 entries
View as:

A Phase 1 Study of S-3304 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00033215 Org: User:
Start: 11/30/01 End: 03/12/03 Due: 03/12/04

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00788528 Org: User:
Start: 08/31/08 End: 03/31/10 Due: 03/31/11

A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT06775730 Org: User:
Start: 12/30/24 End: 04/03/25 Due: 04/03/26

Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00078390 Org: User:
Start: 02/28/03 End: 10/26/06 Due: 10/26/07

A Study to Investigate How Respiratory Syncytial Virus (RSV) Infection Develops and Changes Over Time in Pediatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT06746051 Org: User:
Start: 12/09/24 End: 03/31/25 Due: 03/31/26

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05305547 Org: User:
Start: 08/03/22 End: 05/24/24 Due: 05/24/25

Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments

Phase: N/A Priority: Normal
NCT ID: NCT04607707 Org: User:
Start: 07/07/20 End: 04/30/21 Due: 04/30/22

A Study to Investigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT01054443 Org: User:
Start: 03/18/10 End: 11/24/10 Due: 11/24/11

Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures

Phase: N/A Priority: Normal
NCT ID: NCT02389621 Org: User:
Start: 06/15/15 End: 04/19/17 Due: 04/19/18

A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00459745 Org: User:
Start: 04/30/07 End: 07/31/09 Due: 07/31/10

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Phase: N/A Priority: Normal
NCT ID: NCT03032380 Org: User:
Start: 10/24/17 End: 04/01/19 Due: 04/01/20

Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity

Phase: N/A Priority: Normal
NCT ID: NCT00729469 Org: User:
Start: 07/31/08 End: 08/31/09 Due: 08/31/10

A Study of S-892216 in Participants With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT06928051 Org: User:
Start: 06/01/25 End: 11/30/25 Due: 11/30/26

Evaluation of S-600918 in Adults With Refractory Chronic Cough

Phase: N/A Priority: Normal
NCT ID: NCT04110054 Org: User:
Start: 02/13/20 End: 12/28/20 Due: 12/28/21

Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

Phase: N/A Priority: Normal
NCT ID: NCT02638337 Org: User:
Start: 01/26/16 End: 07/05/17 Due: 07/05/18

Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06106334 Org: User:
Start: 11/15/23 End: 02/14/24 Due: 02/14/25

A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03395353 Org: User:
Start: 01/29/18 End: 07/04/20 Due: 07/04/21

S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05101070 Org: User:
Start: 05/30/22 End: 04/16/27 Due: 04/16/28

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Phase: N/A Priority: Normal
NCT ID: NCT01586364 Org: User:
Start: 05/08/06 End: 12/22/08 Due: 12/22/09

A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection

Phase: N/A Priority: Normal
NCT ID: NCT04355169 Org: User:
Start: 11/06/20 End: 01/04/21 Due: 01/04/22

A Study of S-268019 for the Prevention of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05212948 Org: User:
Start: 12/25/21 End: 07/19/23 Due: 07/19/24

Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections

Phase: N/A Priority: Normal
NCT ID: NCT03780140 Org: User:
Start: - End: - Due: -

A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00630539 Org: User:
Start: 08/31/07 End: 02/29/08 Due: 02/28/09

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet

Phase: N/A Priority: Normal
NCT ID: NCT00747929 Org: User:
Start: 06/30/07 End: 01/31/09 Due: 01/31/10

A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06270511 Org: User:
Start: 03/13/24 End: 06/19/24 Due: 06/19/25